- Home
- / LegoChem Biosciences
LegoChem Biosciences
Stock Price
₩127.2 K
2024-10-28
Market Capitalization
₩4.8 T
2024-10-28
Revenue
₩141.6 B
FY, 2025
LegoChem Biosciences Summary
Company Summary
- Overview
- LegoChem Biosciences (레고켐바이오, LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of medicines. It uses its proprietary medicinal drug discovery technology LegoChemistry to develop antibody-drug conjugates, antibiotics, anticoagulants, and anticancer therapeutics.
- Type
- Public
- Status
- Active
- Founded
- 2006
- Website
- http://www.legochembio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LegoChem Biosciences Financials
Summary Financials
- Revenue (FY, 2025)
- ₩141.6B
- Gross profit (FY, 2025)
- ₩130.4B
- Net income (FY, 2025)
- (₩91.5B)
- Cash (FY, 2025)
- ₩98.6B
- EBIT (FY, 2025)
- (₩105.1B)
- Enterprise value
- $4.7T
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026